Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Optimized Microscope Hardware Developed for Accurate Image Classification

By LabMedica International staff writers
Posted on 03 Dec 2019
Despite the widespread automation enabled by new post-processing software, the physical layout of the standard microscope has still changed relatively little as it is, for the most part, still optimized for a human viewer to peer through and inspect what is placed beneath.

A microscope has been developed that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task. More...
Rather than diffusing white light from below to evenly illuminate the slide, engineers developed a bowl-shaped light source with LEDs embedded throughout its surface. This allows samples to be illuminated from different angles up to nearly 90 degrees with different colors, which essentially casts shadows and highlights different features of the sample depending on the pattern of LEDs used.

An international team of bioengineers working with Duke University (Durham NC, USA) fed the microscope hundreds of samples of malaria-infected red blood cells prepared as thin smears, in which the cell bodies remain whole and are ideally spread out in a single layer on a microscope slide. Using a type of machine learning algorithm called a convolutional neural network; the microscope learned which features of the sample were most important for diagnosing malaria and how best to highlight those features.

The algorithm eventually landed on a ring-shaped LED pattern of different colors coming from relatively high angles. While the resulting images are noisier than a regular microscope image, they highlight the malaria parasite in a bright spot and are correctly classified about 90% of the time. Trained physicians and other machine learning algorithms typically perform with about 75% accuracy. The team also showed that the microscope works well with thick blood smear preparations, in which the red blood cells form a highly non-uniform background and may be broken apart. For this preparation, the machine learning algorithm was successful 99% of the time.

Roarke Horstmeyer, PhD, an assistant professor of biomedical engineering and senior author of the study, said, “A standard microscope illuminates a sample with the same amount of light coming from all directions, and that lighting has been optimized for human eyes over hundreds of years. But computers can see things humans can't. So not only have we redesigned the hardware to provide a diverse range of lighting options, we've allowed the microscope to optimize the illumination for itself.” The study was published in the November, 2019 issue of the journal Biomedical Optics Express.

Related Links:
Duke University


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
8-Channel Pipette
SAPPHIRE 20–300 µL
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.